OnKure Therapeutics, Inc. (OKUR)
3.86
-0.08
(-2.03%)
USD |
NASDAQ |
Aug 24, 16:00
3.86
0.00 (0.00%)
After-Hours: 20:00
OnKure Therapeutics Net Income (Quarterly) : -15.35M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.35M |
| March 31, 2026 | -15.16M |
| December 31, 2025 | -13.50M |
| September 30, 2025 | -14.70M |
| June 30, 2025 | -15.39M |
| March 31, 2025 | -15.92M |
| December 31, 2024 | -35.19M |
| September 30, 2024 | -11.56M |
| June 30, 2024 | -14.14M |
| March 31, 2024 | -9.536M |
| December 31, 2023 | -9.455M |
| September 30, 2023 | -19.20M |
| June 30, 2023 | -19.53M |
| Date | Value |
|---|---|
| March 31, 2023 | -15.11M |
| December 31, 2022 | -13.60M |
| September 30, 2022 | -13.01M |
| June 30, 2022 | -12.31M |
| March 31, 2022 | -13.04M |
| December 31, 2021 | -10.61M |
| September 30, 2021 | -12.74M |
| June 30, 2021 | -9.216M |
| March 31, 2021 | -7.212M |
| December 31, 2020 | -6.253M |
| September 30, 2020 | -5.094M |
| June 30, 2020 | -3.687M |
| March 31, 2020 | -4.431M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 51.29M |
| Theriva Biologics, Inc. | -3.217M |
| Nkarta, Inc. | -40.37M |
| Unicycive Therapeutics, Inc. | -1.722M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 15.35M |
| EPS Diluted (Quarterly) | -0.3077 |
| Enterprise Value | -15.90M |
| Earnings Yield | -90.56% |
| Normalized Earnings Yield | -90.56 |